First-lineGlucophage

Metformin

Biguanide oral hypoglycaemic

First-line oral agent for GDM and pre-existing T2DM in pregnancy.

Oral

First-line for

  • Gestational diabetes (when diet/exercise fail)
  • Type 2 DM in pregnancy
  • PCOS-related anovulation / fertility

Mechanism

Activates AMPK → ↓ hepatic gluconeogenesis, ↑ peripheral insulin sensitivity. Does not cause hypoglycaemia alone.

“GI-LAC”

  • GI upset most common SE
  • Lactic acidosis (rare, renal)
  • Acidosis: hold if eGFR <30
  • Combine with insulin if targets not met

Dosing

Start
500 mg OD with food
Titrate
↑ weekly to 500–1000 mg BD–TDS
Max
2,500–3,000 mg/day divided

Contraindications

  • AbsoluteeGFR <30 mL/min
  • AbsoluteAcute metabolic acidosis, severe sepsis
  • CautionPause around iodinated contrast & surgery

Side effects

  • Nausea, diarrhoea, abdominal pain
  • Metallic taste
  • Vit B12 deficiency (long-term)
  • Lactic acidosis (rare)

Fetal & maternal notes

  • Crosses placenta — no teratogenicity signal.
  • Long-term follow-up of offspring reassuring (MiG-TOFU).
  • Safe in breastfeeding.

Key interactions

  • Iodinated contrast

    Caution

    ↑ lactic acidosis risk — hold 48 h

  • Insulin

    OK

    Synergistic — common combination

  • Alcohol

    Caution

    ↑ lactic acidosis

Clinical pearls

  • 💡 Start before insulin in GDM unless severe hyperglycaemia.
  • 💡 Continue intrapartum; review postpartum at 6 weeks with OGTT.

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.